Professor Sir Andrew McMichael joins Scientific Advisory Council of Oxford Vacmedix
World-class immunologist to advise Oxford Vacmedix on development of novel cancer vaccines. Oxford Vacmedix, a UK-based biopharma company focused on the development of cancer vaccines, announced today that Professor Sir Andrew McMichael will join the company’s Scientific Advisory Council. Sir Andrew is an immunologist, Emeritus Professor, former Professor of Molecular Medicine, and previously Director of […]
Professor Sir Andrew McMichael joins Scientific Advisory Council of Oxford Vacmedix Read More »